1998년 개설되어 24년의 역사를 자랑하는 대다모의 뿌리깊은 탈모커뮤니티 대다모의 우리들의 이야기게시판입니다.

탈모와 관련된 자유로운 글을 올리는 공간입니다.

지난 주 댓글 랭킹

  • 1등 회원등급 K4958360347
  • 2등 회원등급 K4993236009
  • 3등 회원등급 K4971258010
  • 4등 회원등급 K29643000722308141718
  • 5등 회원등급 padakpadak
  • 6등 회원등급 K5003734967
  • 7등 회원등급 K4997213199A
  • 8등 회원등급 05년생운동선수
  • 9등 회원등급 dnheg
  • 10등 회원등급 락켓롤

젠장..글락소에서 두타의 탈모치료제로써의 3상 임상실험을 취소했답니다.

  • 23년 전

  • 1,674
0
November 11, 2002 - Hairlosshelp previously reported the news that Glaxo would be resuming Phase 3 hair loss trials. According to our sources they had already selected the sites for the studies and the trials were scheduled to begin in March 2003.

However late last week we received word that Glaxo has now called off the Phase 3 hair loss trials. This is now the second time that Glaxo has pulled the plug on its Phase 3 hair loss trials.

According to our source, the reason for this is that Glaxo's management does not think that Dutasteride will be able to be sufficiently differentiated from Propecia in the consumers mind to make the drug significantly profitable. We do not have any confirmation from Glaxo as to their reason why they pulled the plug.

Fortunately the U.S. Food and Drug Administration (FDA) has approved Dutasteride, also known as under its brand name Avodart®, for the treatment of symptomatic benign prostatic hyperplasia (BPH) in men with an enlarged prostate.

This means that hair loss sufferers can still get this drug if its prescribed for off-label purposes by their physicians.

Dutasteride, a second-generation 5 alpha-reductase inhibitor, is the first and only medicine to inhibit both the type 1 and type 2 enzymes responsible for the conversion of testosterone to DHT (dihydrotestosterone), the primary cause of prostate growth. Dutasteride's dual inhibition decreases levels of DHT by 90 percent at two weeks and 93 percent at two years.

According to Glaxo, Dutasteride will be available in pharmacies in December 2002.

For more information about Dutasteride (Avodart®) visit www.dutasteride.org. />


SITE RESOURCES
Official Dutasteride Fact Sheet
Dutasteride Phase 2 Clinical Trial Results
New Dutasteride Study


OTHER RESOURCES (opens in new window)
Glaxo corporate web site
Merrill Lynch Global Pharmaceutical Investor Conference - September 25, 2001
Lehman Brothers - Dutasteride presentation - October 10, 2001
Bear Stearns HealthCare Conference - September 18, 2002




모발이식 포토&후기

1 16

우리동네 모발이식 병원지도

병원지도